首页> 外文期刊>Vascular >Development of novel patient selection criteria for a short stay endovascular aneurysm repair pathway: Improving patient selection for short stay endovascular aneurysm repair
【24h】

Development of novel patient selection criteria for a short stay endovascular aneurysm repair pathway: Improving patient selection for short stay endovascular aneurysm repair

机译:短暂停留血管内动脉瘤修复途径的新型患者选择标准的发展:改善短暂停留血管内动脉瘤修复的患者选择

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives A short-stay endovascular aneurysm repair (SS-EVAR) pathway for infrarenal abdominal aortic aneurysms offers the potential to improve service efficiency and patient satisfaction by reducing the hospital length of stay. This study aimed to determine whether the implementation of a novel set of patient selection criteria for a theoretical SS-EVAR pathway could facilitate an expansion of the proportion of suitable patients, whilst maintaining patient safety and limiting unplanned emergency readmissions. Methods Two SS-EVAR selection criteria (low and high risk) were generated based upon patient pre-operative comorbidities. The low risk criteria essentially selected fit and healthy individuals, whereas the high risk criteria included patients with a range of comorbidities that could still theoretically enable enrolment onto a SS-EVAR pathway. A retrospective analysis, whereby both criteria were applied to all elective EVARs recorded in the National Vascular Registry between 2013 and 2016 at a single tertiary vascular unit was performed. Rates and timings of postoperative complications, reinterventions and unplanned readmissions for patients meeting each criteria were assessed. Results In total, 188 patients were included (92% male, mean age 75.4 +/- 7.2 years). Twenty-nine patients (15%) met the low risk criteria. Two (7%) of these experienced an inpatient complication which were both detected within 24 h of operation (including one who required reintervention), and no patients in this group had an unplanned readmission within 30 days. One-hundred and ten patients (59%) met our high risk criteria and 19 (17%) experienced an inpatient complication, with 4 (4%) of these occurring beyond 24 h post-EVAR (three urinary problems and one acute on chronic kidney injury). Six (6%) of these patients required a reintervention; however, all of these complications were detected within 24 h. Two (2%) high risk cohort patients required unplanned readmission within 30 days for a femoral pseudoaneurysm and musculoskeletal back pain. Conclusions With high risk patient selection criteria and appropriate post-operative safeguards, up to 60% of infrarenal abdominal aortic aneurysms patients could be safely enrolled onto a next-day discharge SS-EVAR pathway with minimal readmissions, thus allowing more effective resource utilisation.
机译:目的是一种短暂的血管内动脉瘤修复(SS-EVAR)型腹膜主动脉瘤的途径,通过减少医院的住宿时间,提供了提高服务效率和患者满意度的潜力。该研究旨在确定理论上SS-Evar途径的新型患者选择标准的实施是否可以促进合适患者的比例的扩大,同时维持患者安全性并限制无计划的紧急入院。方法基于患者的患者的患者预次组合性产生了两个SS-EVAR选择标准(低风险)。低风险标准基本上选择了适合和健康的个体,而高风险标准包括患有一系列合并症的患者仍然可以理论上能够进入SS-Evar途径。回顾性分析,其中两个标准都适用于2013年和2016年在国家血管登记处记录的所有选修evar,在单一的三级血管单位上进行。评估术后并发症,重新纳米并发症,重新纳费力和计划生育的患者的速度和时间进行评估。结果总计,包括188名患者(92%的男性,平均年龄75.4 +/- 7.2岁)。二十九名患者(15%)达到了低风险标准。其中两(7%)经历了在经营24小时内检测到的住院并发症(包括需要重新营养的人),而本集团的患者在30天内没有意外的再入住。一百十岁的患者(59%)达到了我们的高风险标准,19(17%)经历了住院性并发症,其中4(4%)在EVAR后24小时超过24小时(急性问题和慢性急性问题肾损伤)。六(6%)这些患者需要重新营养;但是,在24小时内检测到所有这些并发症。两(2%)高风险队队患者在30天内需要无计划的入睡,股骨伪肿瘤和肌肉骨骼背部疼痛。结论具有高风险患者选择标准和适当的术后保障措施,高达60%的Infrarenal腹主动脉瘤患者可以安全地注册到下一天的放电SS-Evar途径,具有最小的入伍,从而允许更有效的资源利用率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号